Bortezomib, thalidomide, and dexamethasone for relapsed multiple myeloma: add it up and wait.
暂无分享，去创建一个
[1] S. Jagannath,et al. Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma , 2005, British journal of haematology.
[2] D. Esseltine,et al. Phase 1 trial of the proteasome inhibitor bortezomib and pegylated liposomal doxorubicin in patients with advanced hematologic malignancies. , 2005, Blood.
[3] D. Weber,et al. VTD (Velcade, Thalidomide, Dexamethasone) as Primary Therapy for Newly-Diagnosed Multiple Myeloma. , 2004 .
[4] D. Esseltine,et al. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma , 2004, British journal of haematology.
[5] T. Libermann,et al. Molecular sequelae of proteasome inhibition in human multiple myeloma cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.